Torrent Pharmaceuticals
Update in progressTORNTPHARM.NS (NSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Torrent Pharmaceuticals Limited engages in R&D, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. It offers products across diabetes, antimicrobial, cardiovascular, urology, gynecology, oncology, GI, nephrology, neuro-psychiatry, dermatology, pain, anti-infectives, vitamins and minerals, and provides contract manufacturing. Brands include Tedibar, Shelcal, Unienzyme, Ahaglow. Founded 1959 as Trinity Laboratories; renamed 1971. Based in Ahmedabad, India. A subsidiary of Torrent Investments Limited.
Company score
- Sentiment
- 0.65
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.01
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.12
- Governance
- 0.30
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.10
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.38
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNSE (NSI)
- LocationIndia
- CEOMr. Sanjay Gupta
- Founded1959
- Employees18,258
- Websitewww.torrentpharma.com
Identifiers
- ISININE685A01028